Larry Wickerham, MD, and Harry D. Bear, MD, PhD
		
		
        
		
		
		
		Larry Wickerham, MD, and Harry D. Bear, MD, PhD, discuss three clinical trials:
•          B-40, the only study to combine neoadjuvant and adjuvant chemotherapy with bevacizumab
•          B-51, on radiation to the chest wall
•          Alliance trial, on lymph node dissection
			
			
     	
    
       
       
    		Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS
		
		
        
		
		
		
		Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS, discuss the role of ovarian suppression and hormonal therapy in premenopausal women.
			
			
     	
    	
    
       
       
    		Clifford A. Hudis, MD, FACP
		
		
        
		
		
		
		Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract P5-19-09, “Stage 1 results from MDV3100-11: A two-stage study of enzalutamide, an androgen receptor inhibitor, in advanced androgen receptor–positive triple-negative breast cancer,” presented by Tiffany A. Traina, MD.